MARKETS / NYSE / CYH
NYSE · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · MID CAP

Community Health Systems, Inc. CYH

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$12.5B
▼ 1.2% vs FY2024
EPS · FY25
$3.77
Dividend / sh · FY25
Payout · FY25
ROE · FY25
Net margin · FY25
4.1%
Dividend coverage
11.8×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 12.5B
Revenue, FY2025 · full 18-year series below
Revenue Net income
510152012.50.52008201120142017202020232025
510152012.50.52016201920222025

4 cents of every revenue dollar became profit this year.

Per share
USD 3.77
Diluted EPS, FY2025
EPS Dividend
2463.772008201120142017202020232025
2463.772016201920222025

Earnings covered the dividend 11.8 times — the rest stayed in the company.

Profitability
Return on equity, FY2025
ROE
4812162008201120142017202020232025
4812162016201920222025
Operating margin11.9%
Net margin4.1%
Return on assets3.7%

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+1.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+0.7%
+1.2%
Net income
+122.8%
−0.1%
+12.4%
+4.1%
EPS, diluted
+120.8%
−3.0%
+10.7%
+1.5%
Returned to shareholders
+81.2%
+18.6%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.14B
Shares outstanding, FY2025
0.090.142008201120142017202020232025
0.110.142016201920222025
Change, 5 years+7.0%
Change, 10 years+22.9%

The share count grew 7% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 13.2B
total assets, end of FY2025
Total assetsUSD 13.2B
EquityUSD -1.4B
CashUSD 260.0M
Gross debtUSD 10.4B
Net debtUSD 10.1B
Current ratio1.46×

Net debt stands at -726% of equity.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
12.5
12.6
12.5
12.2
12.4
11.8
13.2
14.2
15.4
18.4
·
·
·
·
·
·
·
·
Operating income $B
1.5
0.5
1.0
0.8
1.4
1.1
0.7
0.2
−1.9
−0.9
1.3
1.3
0.9
1.2
1.1
1.1
1.1
1.0
EBITDA $B
·
·
·
·
·
·
1.3
0.9
−1.0
0.2
2.5
2.5
1.7
2.0
1.8
1.7
1.6
1.5
Income tax $B
0.0
0.1
0.2
0.2
0.1
−0.2
0.2
−0.0
−0.4
−0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
Net income $B
0.5
−0.5
−0.1
0.0
0.2
0.5
−0.7
−0.8
−2.5
−1.7
0.2
0.1
0.1
0.3
0.2
0.3
0.2
0.2
EPS, diluted $
3.77
−3.90
−1.02
0.35
1.76
4.39
−5.93
−6.99
−22.00
−15.54
1.37
0.82
1.51
2.96
2.23
3.01
2.66
2.32
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
0.25
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
8
·
·
·
·
ROE %
·
·
·
·
·
·
·
·
−580.0
−61.1
3.9
2.6
4.9
10.4
8.8
13.5
12.5
·
Shares out B
0.14
0.14
0.14
0.13
0.13
0.13
0.12
0.12
0.11
0.11
0.11
0.12
0.10
0.09
0.09
0.09
0.09
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
52 of 52
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed